ORAI2 and astrocytoma (excluding glioblastoma): When we classified the data according to glioma tissue type in the French and TCGA datasets, we found that the expression level of Orai2 in GBMs was also higher than that of astrocytomas, oligoastrocytomas, and oligodendrogliomas.